Every 8-K that Enovix Corporation (ENVX) has filed with the SEC in the last 24 months is listed below, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.
A 8-K covers material events a company has to report between its quarterly reports, so if you follow ENVX and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full ENVX filings page.
Enovix Corporation declared a no-cost warrant dividend, with approximately 65.6 million warrants expected to be distributed. Common stockholders of record November 13, 2026 receive one warrant for every four common shares, rounded down; holders of its 2028 and 2030 convertible notes on that date also receive warrants on an as-converted pass-through basis. Distribution is expected on or about November 18, 2026.
Each warrant buys one common share for $3.00, payable in cash or by surrendering 2028 Notes at face value; 2030 Notes are ineligible for exercise. Surrendered 2028 Notes will be cancelled, and Enovix receives cash only on cash exercises. Scheduled expiration is April 28, 2028, subject to early expiration if common-stock VWAP equals or exceeds 110% of the then-applicable cash exercise price on 20 trading days in any 30-consecutive-trading-day period after issuance.
Enovix also repurchased $100 million aggregate principal of its 2030 Notes for approximately $63.1 million; it said this increased net cash (cash–debt) by approximately $36.9 million. Preliminary unaudited Q3 2026 revenue was $11.0 million, up 38% year over year and above its $9 million to $10 million guidance range. It reported an initial 100,000-unit drone-battery order, with deliveries scheduled in the first half of 2027.
Enovix Corporation (ENVX) clarified that an article-reported estimate of around $100 million in 2027 revenue was not a company-authorized disclosure and should not be relied on as company guidance. The company said the shipments described in The Electric’s October 21, 2026 article went to a smart eyewear customer, not a smartphone maker.
Enovix said it had shipped approximately 17,000 production sample cells to that customer as of the end of the third quarter of 2026, out of a 50,000 pack order. It said its $216 million drone, defense and industrial pipeline as of quarter-end is expected to be the primary driver of revenue growth, and it expects to provide updated guidance with third-quarter results on November 12, 2026.
Enovix Corporation (ENVX) reported preliminary, unaudited Q3 2026 revenue of $11.0 million, up 38% year over year and above guidance of $9.0 million to $10.0 million. GAAP operating loss was $39.294 million, versus non-GAAP operating loss of $29.215 million; GAAP and non-GAAP net loss per share were ($0.19) and ($0.14). Cash and cash equivalents were approximately $512 million as of October 4, 2026.
The drone, defense and industrial pipeline grew 18% to approximately $216 million, including a drone pipeline of approximately $150 million, up 48%. Enovix defines its pipeline as estimated peak annual production value of identified design opportunities, not orders, backlog or committed revenue. The company is investing $19 million now to double capacity at its Korean plant; defense and drone customers accounted for approximately 70% of Q3 revenue. Full results are expected on or about November 12, 2026.
Steve Bakos was promoted from senior vice president of worldwide sales to chief revenue officer and general manager, leading global defense and commercial business. James Wilcox was promoted to vice president of corporate strategy, and Dan Wark joined full-time to lead a new global supply chain organization.
Enovix Corporation reported a leadership change and related updates. On August 13, 2026, President and Chief Executive Officer Raj Talluri resigned as CEO, president and director to pursue another opportunity; the company states his resignation did not involve any disagreement over operations, policies or practices and that he will assist with an orderly transition.
Effective August 14, 2026, the Board appointed its chairman and largest shareholder T.J. Rodgers as Executive Chairman and named Ryan Benton, the current Chief Financial Officer, as Interim Chief Executive Officer while a search is conducted for a permanent CEO. Rodgers emphasized this is a CEO transition rather than a strategy transition.
Enovix reaffirmed its third quarter 2026 financial guidance previously provided on August 12, 2026 and highlighted technical progress, including achieving 1,000-cycle life on its 100% silicon-anode AI-class smartphone batteries. Management reiterated focus on smartphone qualification programs, scaling AI-1 smart eyewear battery production, and expanding the MX-1 platform for defense and drone applications.
Enovix Corporation reported second quarter 2026 revenue of $9.0 million, up 21% year-over-year and 19% sequentially, marking its fifth consecutive quarter of year-over-year revenue growth. Year-to-date revenue reached $16.6 million, up 32% from the first half of 2025.
GAAP gross margin was 14.4% and non-GAAP gross margin 19.9%, both lower than a year earlier on a shift in product mix, though the company recorded its seventh consecutive quarter of positive gross profit. GAAP net loss per share was $0.20 and non-GAAP net loss per share $0.13 in the quarter.
Enovix ended the quarter with about $552.1 million in cash, cash equivalents, marketable securities, and restricted cash, and year-to-date free cash flow was an outflow of $67.7 million. The drone, defense, and industrial pipeline in South Korea increased 41% to roughly $183 million, while a 50,000-pack smart-eyewear order began shipping. Third quarter 2026 revenue is projected at $9.0–$10.0 million, up approximately 13% to 25% year-over-year.
Enovix Corporation is appointing Dr. Michael Vyvoda as Chief Operating Officer effective July 29, 2026, reporting to President and CEO Dr. Raj Talluri. He will oversee global manufacturing, supply chain and operations engineering as the company ramps high-volume battery production in Malaysia and Korea with R&D support from India.
Under his employment agreement, Dr. Vyvoda will receive a $440,000 annual base salary and an annual target bonus equal to 60% of salary. He is also being granted restricted stock units with a fair market value of $4.0 million that vest over time, plus $100,000 of fully vested RSUs. The agreement includes cash severance equal to nine months of base salary, continued health coverage, a pro-rated bonus and potential accelerated equity vesting if he is terminated without cause or resigns for good reason, with enhanced vesting protection in connection with a change of control.
The company highlights that in its first quarter 2026 results it grew revenue 49% year over year to $7.6 million, delivered a sixth consecutive quarter of positive gross profit and expanded its global pipeline for Korea-manufactured products to more than $130 million. Production is underway for silicon-anode batteries for smart eyewear following a commercial production order of approximately 50,000 units, while smartphone qualification and the new MX-1 platform for drone and defense markets continue to progress.
Enovix Corporation reported the results of its 2026 Annual Meeting of Stockholders. Holders of 153,161,477 common shares, representing 70.3% of voting power as of the April 13, 2026 record date, were present in person or by proxy, establishing a quorum.
Stockholders elected all eight director nominees to one-year terms, with each receiving more votes "for" than "withheld." They also approved, on an advisory basis, the compensation of the company’s named executive officers. In addition, stockholders ratified the appointment of Deloitte & Touche LLP as independent registered public accounting firm for the fiscal year ending January 3, 2027.
Enovix Corporation reported first quarter 2026 revenue of $7.6 million, up 49% year-over-year and above the high end of its guidance. Growth was driven mainly by defense and industrial shipments from its South Korea operations. GAAP gross margin improved to 20.4%, while non-GAAP gross margin reached 26.3%, marking a sixth consecutive quarter of positive gross profit.
The company posted a GAAP net loss of $38.3 million, or $0.18 per share, and a non-GAAP net loss of $29.5 million, or $0.14 per share. Net cash used in operating activities was $33.1 million, and free cash flow was an outflow of $36.3 million. Enovix ended the quarter with $582.7 million in cash, cash equivalents and marketable securities.
Operationally, Enovix advanced smartphone battery qualification, began initial smart eyewear battery shipments, and launched its MX-1 drone battery platform. For the second quarter of 2026, it guided revenue to $8.0–$9.0 million, non-GAAP loss from operations to $29.0–$32.0 million, and capital expenditures to $9.0–$13.0 million.
Enovix Corporation has appointed industry veteran Steve Bakos as Senior Vice President of Worldwide Sales, a new role reporting to Chief Business Officer Samira Naraghi. The move supports commercial scale-up and revenue growth as Enovix prepares to launch its flagship 100% silicon-anode smartphone batteries and continues scaling its silicon-enhanced products from Korea.
Bakos brings more than 35 years of global semiconductor sales experience, including leading major accounts such as Apple at Infineon and prior VP roles at multiple analog and power semiconductor companies. Enovix also highlighted expanding commercial momentum across smartphones, smart eyewear, drones and defense applications.
The company announced it has reached alignment with its lead smartphone customer on a new silicon-specific qualification framework that better mirrors real-world conditions than legacy 0.7C testing. This updated testing extends duration and is producing results that are approaching required performance thresholds, which Enovix believes helps remove a key structural barrier to qualification and supports broader commercial opportunities.
Enovix Corporation reported strong top-line growth but continued losses, and expanded its share repurchase capacity. For full year 2025, revenue rose to $31.8 million from $23.1 million, a 38% increase, while GAAP gross margin improved to 19.2% from negative levels in 2024. Fourth quarter 2025 revenue reached $11.3 million, up from $9.7 million, with GAAP gross margin of 22.1%.
The company still posted a 2025 GAAP net loss of $156.7 million, though this narrowed from $222.2 million in 2024, and free cash flow improved to an outflow of $113.5 million from $184.8 million. Year-end cash, cash equivalents and marketable securities totaled about $621 million. Enovix’s board authorized an additional share repurchase program of up to $75 million, alongside remaining capacity of about $1.6 million under a prior plan. For first quarter 2026, the company forecasts revenue of $6.5–7.5 million and non-GAAP net loss per share of $0.14–0.18.
Enovix Corporation filed a current report describing a leadership change and preliminary 2025 revenue information. The company’s Chief Operating Officer, Ajay Marathe, informed Enovix on January 19, 2026 that he will retire effective February 17, 2026. The company states that his decision to retire is not due to any disagreement about its operations, policies or practices.
Enovix also furnished a press release that contains certain preliminary, unaudited financial information about its revenue growth during 2025. That press release is provided as an exhibit and is treated as furnished, not filed, under securities law, meaning it is not automatically subject to certain liability provisions or incorporated into other filings unless specifically referenced.
Enovix Corporation furnished an update on its third-quarter 2025 results. The company announced that it issued a press release with financial results for the quarter, and attached it as Exhibit 99.1.
The disclosure was furnished under Item 2.02 and is not deemed “filed” for purposes of Section 18 of the Exchange Act, nor incorporated by reference into other filings unless specifically referenced.
Enovix Corporation completed a private offering of $360 million aggregate principal amount of 4.75% Convertible Senior Notes due 2030. The notes are unsecured, pay 4.75% interest semiannually, and are convertible into common stock at an initial rate of 89.2160 shares per $1,000 principal amount, implying an initial conversion price of approximately $11.21 per share, a premium of about 22.5% over the last reported share price on September 10, 2025.
The company received net proceeds of approximately $348.6 million, using about $45.3 million to enter capped call transactions intended to offset interim dilution from conversions up to cap prices between $16.47 and $20.13. Enovix plans to use the remaining funds for general corporate purposes, including potentially funding acquisitions in the battery ecosystem. Based on the initial maximum conversion rate of 109.2896 shares per $1,000 principal amount, up to 39,344,256 shares of common stock may ultimately be issuable upon conversion, highlighting meaningful potential equity dilution alongside the added capital.